Dr. Caudle is an associate professor of breast surgical oncology at the University of Texas MD Anderson Cancer Center. Her research has centered on the surgical management of nodal disease in breast cancer, specifically the development of targeted axillary dissection, a novel surgical technique that improves axillary node staging after neoadjuvant chemotherapy. She also has research interests focusing on improving quality in breast cancer surgery and methods for improving dissemination and implementation of clinical trial data.

Professor Chan graduated from the University of Melbourne, and subsequently obtained her Fellowship in Medical Oncology and a Masters of Medicine in Palliative Care.
She worked in the area of cancer genetics in City Hospital, Nottingham and breast cancer in Princess Margaret Hospital, Toronto. She has worked solely in the area of breast cancer for nearly 20 years and has a strong commitment to breast cancer research, having personally recruited over 1100 patients to clinical trials and has served on the academic steering committee of three international studies. She has authored >100 breast cancer publications in journals including New England Journal of Medicine, Lancet Oncology and Journal of Clinical Oncology; and has been a accessor for UK NHS, young investigator and NHMRC grants.
She is an adjunct professor in the school of medicine at Curtin University and was a founding member of Breast Cancer Research Centre-WA. She established the Helen Sewell Breast Cancer Tumour Bank which has led to the collection of over 3000 annotated breast cancer samples for future research. She is currently the Director of the Breast Clinic Trials Unit of the Breast Cancer Research Centre-WA, based at Hollywood Private Hospital in Perth, Western Australia.
She was awarded the Western Australia of Year Award in Professions 2016 for her contribution in the field of science at a state, national and international level and was a finalist for Australian of the Year in 2017.

Prof Ray Chan (RN, PhD, FACN) is Chair in Cancer Nursing, jointly appointed by Princess Alexandra Hospital, Metro South Health and Queensland University of Technology. Prof Chan’s research program focuses on optimising models of care and health services’ responses to address the needs of people affected by cancer in the survivorship phase. Prof Chan has published 140 peer-reviewed articles. In total, he has attracted >$21.5 million AUD of research funding as Chief Investigator. Prof Chan is an internationally recognised expert in cancer survivorship. He is the current Chair for the Multinational Association for Supportive Care in Cancer (MASCC) Survivorship Group.

Michael Chao is a radiation oncologist specializing in breast and prostate cancers from the University of Melbourne, the Olivia Newton John Cancer and Wellness Centre (ONJCWC) and Genesis Care Victoria (GCV). He is actively involved in both investigator initiated and multicenter studies at the ONJCWC and GVC. His main areas of interest include the use of preoperative radiotherapy in locally advanced breast cancer before definitive mastectomy and autologous breast reconstruction, the use of silicone gels to diminish the incidence of radiation dermatitis in patients undergoing breast/chest wall radiotherapy and the effect of low dose radiation on myocardial function. He is also passionate about the use of high technology such as volumetric arc therapy in breast cancer radiotherapy.

Prof. Louis Chow is Executive Director of the Organization for Oncology and Translational Research in Hong Kong; a distinguished professor of Macau Science Technology; a Medical Director of the Comprehensive Centre for Breast Diseases at the UNIMED Medical Institute in Hong Kong, an honorary professor of the Third Military Medical University; an honorary professor at Ningxia Medical College School of Clinical Medicine in Ningxia, China; an honorary professor at Tohoku University in Sendai, Japan; visiting professor at Wuhan University of Science and Technology; and an honorary consultant of Kiang Wu Hospital in Macau. Professor Chow was the immediate past honorary clinical professor of the clinical trials centre at The University of Hong Kong, past president of the Asian Breast Cancer Society, and former honorary secretary of The Hong Kong Academy of Medicine.
Professor Chow is an expert in cancer research and has obtained a patent on a mouse cell line derived from human malignant cystosarcoma phylloides. In the past few years, he has obtained various research and professional grants for cancer research purposes in the university and contributed as Principal Investigator/Co-investigator of several international clinical trials. Professor Chow has published more than 190 articles in peer-reviewed journals. His key research interests are breast cancer molecular therapy, chemoresistance, chemoprevention and translational research in breast cancer.
Professor Chow was awarded The Kim Hyun-Jib Breast Cancer Research Memorial Award in 2012

Jennifer Chynoweth has worked as an executive in the Australian Public Service for over two decades, working on health and social policy. She is currently leading initiatives at Cancer Australia that aim to improve lung, breast and gynaecological cancer outcomes, and address unwarranted variations in cancer outcomes and experiences for Aboriginal and Torres Strait Islander people.
Jennifer has sponsored the expansion of Aboriginal and Torres Strait Islander cancer control policy at Cancer Australia, notably through publication of the National Aboriginal and Torres Strait Islander Cancer Framework, establishment of the Leadership Group on Aboriginal and Torres Strait Islander Cancer Control and the development of the Optimal Care Pathway for Aboriginal and Torres Strait Islander people with cancer.